Minapharm Pharmaceuticals News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
19 January 01:55 AM

Minapharm Pharmaceuticals (MIPH)

Last update: 18 January 02:04 PM market time.
0.00
5.46
1.58%
Open 344.54
Previous Close 344.54
High 352.40
Low 345.00
Stock Statistics
Volume 47
Turnover 16,358.40
All data are 15 minutes late during market session

News

Photo Archive
3 December 2025 03:06 PM Minapharm’ consolidated net profits retreat to EGP 62m in 9M-25
Cairo - Mubasher: Minapharm Pharmaceuticals generated consolidated net profits after tax of EGP 61.81 million in the first nine months (9M) of 2025, lower year-on-year (YoY) than EGP 73.16 million. The basic and diluted earnings per share (EPS) …
Financial Results
Photo Archive
25 November 2025 04:47 PM Minapharm posts EGP 66.5m standalone net profits in 9M-25; sales hit EGP 2.8bn
Cairo - Mubasher: Minapharm Pharmaceuticals registered an annual surge in non-consolidated net profits after tax to EGP 66.56 million during the first nine months (9M) of 2025, versus EGP 17.13 million. The earnings per share (EPS) dropped to EGP …
Financial Results
Photo Archive
27 May 2024 01:11 PM Investor buys EGP 1.3bn stake in Minapharm Pharmaceuticals
Cairo - Mubasher: The Egyptian Exchange (EGX) on Monday announced the acquisition of 6.36 million shares in Minapharm Pharmaceuticals in a block-trading transaction. The deal has a total value of EGP 1.27 billion. Block-trading transactions …
Mergers and Acquisitions
Photo Archive
27 April 2023 00:11 PM Minapharm Pharmaceuticals’ shareholders nod to 2022 dividends
Cairo - Mubasher: The shareholders of Minapharm Pharmaceuticals greenlighted a cash dividend distribution worth EGP 2.80 per share for 2022. The general assembly meeting approved the announced dividends on 26 April 2023, according to a bourse …
Cash Dividends
Photo Archive
14 March 2023 02:03 PM Minapharm Pharmaceuticals mulls EGP 603m capital hike
Cairo - Mubasher: The board of Minapharm Pharmaceuticals agreed to increase the company’s issued capital by EGP 602.98 million through bonus shares, according to a bourse filing. Under the board’s recommendation, a total of 60.29 million bonus …
Management Decisions
Photo Archive
29 November 2022 04:13 PM Bioventure, Minapharm, MiGenTra to commercialise multiple biosimilar candidates of Alvotech
Mubasher: Dubai-based Bioventure, Minapharm Pharmaceuticals, and MiGenTra GmbH have signed an exclusive licence agreement for the commercialisation of multiple biosimilar candidates developed and manufactured by Alvotech, in Egypt and eighteen …
Global Economy
Photo Archive
30 November 2021 01:17 PM Minapharm sees 75% higher consolidated profits in 9M
Cairo – Mubasher: Minapharm Pharmaceuticals' consolidated net profits jumped by 75.1% to EGP 352.36 million in the first nine months (9M) of 2021, compared to EGP 201.13  million in the year-ago period. The company generated revenues of EGP 2.2 …
Financial Results
The net sales rose to EGP 1.59 billion in the January-September period
11 November 2021 00:09 PM Minapharm Pharmaceuticals reports 135% standalone profit hike in 9M
Cairo – Mubasher: Minapharm Pharmaceuticals reported standalone net profits of EGP 225.63 million in the first nine months of 2021, up by 134.8% year-on-year (YoY) from EGP 96.09 million.  The net sales rose to EGP 1.59 billion in the …
Financial Results
The revenues increased to EGP 1.45 billion in the six-month period
30 August 2021 05:08 PM Minapharm Pharmaceuticals posts 96% profit leap in H1-21
Cairo – Mubasher: Minapharm Pharmaceuticals recorded a 96.47% year-on-year (YoY) hike in its consolidated net profits attributable to the company's owners, logging EGP 255.63 million in the first half (H1) of 2021, compared to EGP 130.11 million.  …
Financial Results
Sales increased to EGP 772.69 million in Q1-21
15 June 2021 03:45 PM Minapharm achieves net profits worth EGP 122m in Q1
Cairo – Mubasher: Minapharm Pharmaceuticals posted consolidated net profits after tax, including minority rights, worth EGP 121.9 million during the January-March 2021 period, compared to EGP 79.24 million in the prior-year period. Sales increased …
Financial Results
The total amount of dividends stands at EGP 33.19 million
28 April 2021 02:25 PM Minapharm's shareholders approve EGP 2.7/shr dividends for 2020
Cairo – Mubasher: The ordinary general meeting (OGM) of Minapharm Pharmaceuticals approved a cash dividend of EGP 2.7 per share for 2020. The total amount of dividends stands at EGP 33.19 million, which will be paid on 30 May, the company said in …
General Assembly
The company will produce 40 million doses of Sputnik per year
25 April 2021 11:31 AM EGX resumes trading on Minapharm's stock
Cairo – Mubasher: The Egyptian Exchange (EGX) resumed trading on the shares of Minapharm Pharmaceuticals as of the beginning of Sunday’s trading session. The company announced signing a contract with the Russian Direct Investment Fund (RDIF) to …
Trading Activities
Minapharm signed deal to produce Sputnik V at its Cairo-based facility
22 April 2021 03:56 PM EGX halts trading on Minapharm's stock
Cairo – Mubasher: The Egyptian Exchange (EGX) halted trading on the shares of Minapharm Pharmaceuticals. Trading will remain suspended on the company’s stock until it responds to news reports about signing an agreement with the Russian Direct …
Trading Activities
Minapharm will manufacture more than 40 million doses annually
22 April 2021 00:30 PM Egypt inks deals to locally produce Russian, Chinese vaccines
Cairo – Mubasher: The Russian Direct Investment Fund (RDIF) signed an agreement with Egypt’s Minapharm Pharmaceuticals and its Berlin-based subsidiary ProBioGen AG to manufacture more than 40 million doses annually of the Russian vaccine against …
Macroeconomics
Minapharm will hold a 49% stake in the new company
31 March 2021 05:58 PM Minapharm to create new Germany-based firm with EUR 10m capital
Cairo – Mubasher: The board of directors of Minapharm Pharmaceuticals decided to proceed with establishing a new Germany-based company which will be affiliated to its 96.79%-owned subsidiary ProBioGen AG. Minapharm will hold a 49% stake in the new …
Companies Investments
The company’s revenues increased to EGP 1.65 billion
29 November 2020 05:40 PM Minapharm Pharmaceuticals posts 184% higher profit in 9M
Cairo – Mubasher: Minapharm Pharmaceuticals registered consolidated net profits of EGP 209.65 million during the first nine months of 2020, up by 183.6% year-on-year (YoY) from EGP 73.91 million, including minority shareholders’ rights. The …
Financial Results
The company generated EGP 1.06 billion in revenue
30 August 2020 01:19 PM Minapharm Pharmaceuticals reports 156% profit hike in H1-20
Cairo – Mubasher: The consolidated net profits of Minapharm Pharmaceuticals soared  by 156% year-on-year (YoY) to EGP 130.11 million in the first half (H1) of 2020, compared to EGP 50.8 million. Revenues increased to EGP 1.06 billion in the …
Financial Results
The deal saw the trading of 1.23 million shares
26 July 2020 01:56 PM Minapharm Pharmaceuticals sees EGP 104m block trading deal
Cairo – Mubasher: The Egyptian Exchange (EGX) announced that a block-trading transaction was executed on the shares of Minapharm Pharmaceuticals. The deal saw the trading of 1.23 million shares at a total value of EGP 104.43 million, according to …
Insider Trading & Treasury Stocks
The company’s net sales amounted to EGP 551.01 million
29 June 2020 04:33 PM Minapharm Pharmaceuticals posts 77% consolidated profit surge in Q1-20
Cairo – Mubasher: The consolidated financial statements of Minapharm Pharmaceuticals reported a 77.3% year-on-year (YoY) profit growth to EGP 75.25 million during the first quarter of 2020, compared to EGP 42.42 million, including minority …
Financial Results
A total of EGP 73.76 million will be paid to shareholders
31 May 2020 11:11 AM Minapharm Pharmaceuticals’ shareholders approve EGP 6/shr dividends for 2019
Cairo – Mubasher: The ordinary general meeting (OGM) of Minapharm Pharmaceuticals approved a cash dividend distribution proposed for 2019. Shareholders will be paid EGP 6 per share on 30 June, according to a statement to the Egyptian Exchange …
General Assembly
The company's sales rose to EGP 2.05 million in 2019
18 May 2020 01:48 PM Minapharm Pharmaceuticals sees 19.5% higher profits in 2019
Cairo - Mubasher: The consolidated financial results of Minapharm Pharmaceuticals showed a 19.45% hike in net profits to EGP 148.41 million during 2019, compared to EGP 124.24 million a year earlier. The company's sales rose to EGP 2.051 million …
Financial Results
The board recommended a cash dividend distribution of EGP 73.76 million
30 April 2020 03:48 PM Minapharm Pharmaceuticals’ standalone profit down 36% in 2019; dividends proposed
Cairo – Mubasher: The standalone financial statements of Minapharm Pharmaceuticals showed a 36% year-on-year (YoY) decline in its net profits during 2019. The company’s net profits stood at EGP 46.035 million last year, down from EGP 72.12 million …
Financial Results
The new company’s issued and paid-in capital stands at EGP 1 million
17 December 2019 11:04 AM Minapharm Pharmaceuticals sets up new firm for trade and distribution
Cairo – Mubasher: Minapharm Pharmaceuticals announced the establishment of an Egyptian joint stock company under the name Minapharm for Trade and Distribution. The pharmaceuticals company owns 95% of the new company’s issued and paid-in capital …
Company News
Net profit fell to EGP 73.9 million
28 November 2019 00:42 PM Minapharm’s consolidated profit drops 37% in 9M
Cairo – Mubasher: Minapharm Pharmaceuticals saw its profit dropping by 37% year-on-year in the first nine months of 2019, the drugmaker’s consolidated financial results showed on Thursday. Net profit fell to EGP 73.9 million ($4.59 million) in the …
Company News
Standalone sales rose to EGP 1.11bn in 9M
15 November 2019 03:43 PM Minapharm Pharmaceuticals posts EGP 28m standalone profit in 9M/19
Cairo – Mubasher: Minapharm Pharmaceuticals has reported a 34.5% year-on-year profit decline during the first nine months of 2019, the company’s standalone financial statements showed. Net profit declined to EGP 27.9 million from January to …
Financial Results